Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer

NCT06322147 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Doublet or triplet chemotherapy combined with cetuximab

Sponsor

Qilu Hospital of Shandong University